RT Journal Article
SR Electronic
T1 High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.20.20178533
DO 10.1101/2020.08.20.20178533
A1 Knabl, Ludwig
A1 Mitra, Tanmay
A1 Kimpel, Janine
A1 Rössler, Annika
A1 Volland, André
A1 Walser, Andreas
A1 Ulmer, Hanno
A1 Pipperger, Lisa
A1 Binder, Sebastian C.
A1 Riepler, Lydia
A1 Bates, Katie
A1 Bandyopadhyay, Arnab
A1 Schips, Marta
A1 Ranjan, Mrinalini
A1 Falkensammer, Barbara
A1 Borena, Wegene
A1 Meyer-Hermann, Michael
A1 von Laer, Dorothee
YR 2020
UL http://medrxiv.org/content/early/2020/08/22/2020.08.20.20178533.abstract
AB Background Early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe.Methods Between April 21 and 27, a cross-sectional epidemiologic study targeting the full population of Ischgl (n = 1867), of which 79 % could be included (n = 1473, incl. 214 children), was performed. For each individual, the study involved a SARS-CoV-2 PCR, antibody testing and structured questionnaires. A mathematical model was used to help understand the influence of the determined seroprevalence on virus transmission.Findings The seroprevalence was 42.4% (95% CI 39.8–44.7). Individuals under 18 showed a significantly lower seroprevalence of 27.1% (95% CI 21.3–33.6) than adults (45%; 95% CI 42.2–47.7; OR of 0.455, 95% CI 0.356–0.682, p< 0.001). Of the seropositive individuals, 83.7% had not been diagnosed to have had SARS-CoV-2 infection previously. The clinical course was generally mild. Over the previous two months, two COVID-19-related deaths had been recorded, corresponding to an infection fatality rate (IFR) of 0.25% (95% CI 0.03–0.91). Only 8 (0.5 %) individuals were newly diagnosed to be infected with SARS-CoV-2 during this study.Interpretation Ischgl was hit early and hard by SARS-CoV-2 leading to a high local seroprevalence of 42.4%, which was lower in individuals below the age of 18 than in adults. Mathematical modeling suggests that a drastic decline of newly infected individuals in Ischgl by the end of April occured due to the dual impact from the non-pharmacological interventions (NPIs) and a significant immunization of the Ischgl population.Funding Helmholtz Association, European Union’s Horizon 2020 research and innovation program, German Research Foundation (DFG), state Tyrol.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTM was supported by the Helmholtz-Association, Zukunftsthema "Immunology and Inflammation" (ZT-0027). MMH has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003480 and the German Research Foundation (DFG) under Germany's Excellence Strategy EXC 2155 project number 390874280. The state Tyrol funded the testing materials used in the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical committee of the Medical University of InnsbruckAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUpon publication of our study, the data and codes will be available from the corresponding authors upon receipt of a suitable request.